Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMID 25655556)

Published in Gastroenterology on February 02, 2015

Authors

Giovanni Dothel1, Maria Raffaella Barbaro1, Hélène Boudin2, Valentina Vasina1, Cesare Cremon1, Luciana Gargano1, Lara Bellacosa1, Roberto De Giorgio1, Catherine Le Berre-Scoul2, Philippe Aubert2, Michel Neunlist2, Fabrizio De Ponti1, Vincenzo Stanghellini1, Giovanni Barbara3

Author Affiliations

1: Department of Medical and Surgical Sciences and Center for Applied Biomedical Research (CRBA), University of Bologna, Italy.
2: Inserm, U913, Institut des Maladies de l'Appareil Digestif du CHU de Nantes; University of Nantes, Nantes, France.
3: Department of Medical and Surgical Sciences and Center for Applied Biomedical Research (CRBA), University of Bologna, Italy. Electronic address: giovanni.barbara@unibo.it.

Articles citing this

Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14

Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside. J Neurogastroenterol Motil (2016) 0.83

The Regulation of Immunological Processes by Peripheral Neurons in Homeostasis and Disease. Trends Immunol (2015) 0.82

Early-life stress origins of gastrointestinal disease: animal models, intestinal pathophysiology, and translational implications. Am J Physiol Gastrointest Liver Physiol (2015) 0.81

Mast Cell-Mediated Mechanisms of Nociception. Int J Mol Sci (2015) 0.80

Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology. Front Immunol (2016) 0.79

Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol (2016) 0.79

A novel enteric neuron-glia coculture system reveals the role of glia in neuronal development. J Physiol (2016) 0.77

Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77

Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B (2016) 0.77

Gene-environment interactions and the enteric nervous system: Neural plasticity and Hirschsprung disease prevention. Dev Biol (2016) 0.77

Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses. Neurogastroenterol Motil (2016) 0.76

New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome. Clin Transl Gastroenterol (2016) 0.75

IBS: Mast cells cause nerves to sprout in patients with IBS. Nat Rev Gastroenterol Hepatol (2015) 0.75

Stress, sex, and the enteric nervous system. Neurogastroenterol Motil (2016) 0.75

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. Ther Clin Risk Manag (2016) 0.75

Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil (2016) 0.75

Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol (2016) 0.75

Gender-related differential effect of tachykinin NK2 receptor-mediated visceral hyperalgesia in guinea pig colon. Br J Pharmacol (2016) 0.75

Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLoS One (2017) 0.75

Early weaning stress induces chronic functional diarrhea, intestinal barrier defects, and increased mast cell activity in a porcine model of early life adversity. Neurogastroenterol Motil (2017) 0.75

Trypsin-protease activated receptor-2 signaling contributes to pancreatic cancer pain. Oncotarget (2017) 0.75